DFB Branded Pharmaceuticals

Michael E. Steadman has been appointed group president and chief operating officer of DFB Branded Pharmaceuticals, a new segment of Fort Worth-based DFB Pharmaceuticals, Inc., which is made up of four divisions: Healthpoint, Ltd., Tissue Management, Coria Laboratories, Ltd., Healthpoint International, and Healthpoint Surgical. Mr. Steadman will manage all operations of the enterprise.

DFB Branded Pharmaceuticals is one of three DFB business segments. The other two are DFB Pharmaceutical Services, represented by DPT Laboratories, Ltd. (San Antonio, Texas, and Lakewood, NJ) and DFB Biotechnology, represented by Phyton Biotech, Inc. (Princeton, NJ, and Ahrensburg, Germany).

“Michael has been an indispensable member of the DFB leadership team since Healthpoint’s inaugural year,” said Mr. Dorman. “He has taken ownership of our company’s destiny and guides us along our path to success. He will no doubt replicate his exemplary leadership for Branded Pharmaceuticals during this next stage of our growth.”

Mr. Steadman has been with DFB for 15 years and was most recently president of Healthpoint Tissue Management. He joined the original Healthpoint, Ltd. in 1992 as director of sales during the company’s first year of business, establishing the field sales organization for Healthpoint’s first branded business, Tissue Management.

Mr. Steadman will work directly with Rob Bancroft, general manager of Healthpoint, and other division leaders for DFB Branded Pharmaceuticals: Steve Clark, president of Coria and Jay Nisbet, senior director of International, as well as DFB Branded Pharmaceutical leaders Duncan Aust, Ph.D., senior vice president, R&D; Mike Bernstein, MPH, vice president, regulatory affairs; Herbert Slade, M.D., chief medical officer; Mike Carmena, senior director, finance and administration; Gerry Keith, deputy general counsel; and Mary Beth Dudley, senior director, human resources.

Mr. Steadman will continue to serve as chairman of the board, DFB Biotech of Curacao N.V. and senior vice president, DFB Pharmaceuticals.